NSE
AVRO INDIA LIMITEDAVROIND
AVRO INDIA LIMITED is a manufacturer of pharmaceutical products.
| Key products | Pharmaceuticals |
|---|---|
| Geography | India |
| Competitors | CIPLA, SUN PHARMA |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹1.8 Cr
Institutional buyers
3 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹4.8 Cr | 91 | — | — | — | — |
| 2 | AVROINDThis | — | — | — | — | — | — |
| 3 | MOBIKWIK | +₹0 Cr | 12 | — | — | — | — |
| 4 | QUADFUTURE | +₹0 Cr | 34 | — | — | — | — |
| 5 | IRMENERGY | — | — | — | — | — | — |
| 6 | MTNL | — | — | — | — | — | — |
| 7 | GATECH | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Weaknesses
- • Limited product diversity
- • Dependent on a few major customers
Opportunities
- • Potential for market expansion in India
- • Increased focus on digital marketing could improve customer reach
Threats
- • Economic downturn affecting consumer spending
- • Rising raw material costs
AI-generated from our data — verify before relying on it.
- 2026-06-17FilingAVRO INDIA LIMITED has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of keGranting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
- 2026-06-12FilingAVRO INDIA LIMITED has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-08FilingAVRO INDIA LIMITED has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-08FilingAVRO INDIA LIMITED has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on JMeeting
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvalsNeutral
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Source PDF → - 1
- 1
- 2
No bulk/block deals for AVROIND in this window.
Results & transcripts
Financial results
None yet.
News & chatter on AVROIND
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.